- Home
- SCLX vs QUCY Comparison
SCLX vs QUCY Comparison
Compare SCLX & QUCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SCLX | QUCY |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | Germany |
| Employees | 34 | 13 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.5M | 48.8M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | SCLX | QUCY |
|---|---|---|
| Price | $5.69 | $1.93 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 92.6K | ★ 7.5M |
| Earning Date | 04-10-2026 | 06-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $122.52 | $74.34 |
| Revenue Next Year | $186.30 | $171.48 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.20 | $0.30 |
| 52 Week High | $34.27 | $4.93 |
Technical Indicators
Market Signals| Indicator | SCLX | QUCY |
|---|---|---|
| Relative Strength Index (RSI) | 38.04 | 48.31 |
| Support Level | $4.20 | $0.38 |
| Resistance Level | $7.77 | $4.93 |
| Average True Range (ATR) | 0.98 | 0.32 |
| MACD | -0.04 | -0.14 |
| Stochastic Oscillator | 1.38 | 16.32 |
Price Performance
Historical ComparisonAbout SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.
About QUCY Mainz Biomed N.V. Ordinary Shares
Quantum Cyber NV is focused on building a diversified platform at the intersection of quantum computing and cybersecurity. It aims to secure critical infrastructure and data against these emerging threats.